A phase I study of olaratumab, an anti-platelet-derived growth factor receptor alpha (PDGFRα) monoclonal antibody, in patients with advanced solid tumors
Title:
A phase I study of olaratumab, an anti-platelet-derived growth factor receptor alpha (PDGFRα) monoclonal antibody, in patients with advanced solid tumors
Author:
Chiorean, E. Gabriela Sweeney, Christopher Youssoufian, Hagop Qin, Amy Dontabhaktuni, Aruna Loizos, Nick Nippgen, Johannes Amato, Robert